Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV

por Spitsin, Sergei, Pappa, Vasiliki, Kinder, Annemarie, Evans, Dwight L., Rappaport, Jay, Douglas, Steven D.
Publicado 2021

Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV

por Barrett, Jeffrey S., Spitsin, Sergei, Moorthy, Ganesh, Barrett, Kyle, Baker, Kate, Lackner, Andrew, Tulic, Florin, Winters, Angela, Evans, Dwight L., Douglas, Steven D.
Publicado 2016

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

por Tebas, Pablo, Spitsin, Sergei, Barrett, Jeffrey S., Tuluc, Florin, Elci, Okan, Korelitz, James J., Wagner, Wayne, Winters, Angela, Kim, Deborah, Catalano, Renae, Evans, Dwight L., Douglas, Steven D.
Publicado 2015

HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic

por Denis, Cecile M., Dominique, Tiffany, Smith, Peter, Fiore, Danielle, Ku, Yi-Chien, Culhane, Angus, Dunbar, Debora, Brown, Dana, Daramay, Menvekeh, Voytek, Chelsea, Morales, Knashawn H., Blank, Michael B., Crits-Christoph, Paul F., Douglas, Steven D., Spitsin, Serguei, Frank, Ian, Colon-Rivera, Krystal, Montaner, Luis J., Metzger, David S., Evans, Dwight L.
Publicado 2021